Rwandan Government subsidizes cost of Drugs for Mental Health Patients
Rwanda is definitely putting the survival of its citizens first. According to All Africa, the country’s Ministry of Health, in partnership with Johnson & Johnson, is subsidizing the cost of drugs for mental health patients.
Prices are being slashed by up to 70% in what is a 5-year deal with the pharmaceutical giant.
Drugs for Schizophrenia, which the Rwanda Biomedical Centre (RBC) has said accounts for 26% of mental illnesses in the country, are being slashed from Rwf30,000 ( ?13,000) down to Rwf5,000 ( ?2100).
The Director of Psychiatric Care at RBC, Jean Damascene Iyamuremye, said:
“Risperdal was introduced 5 years ago. In the beginning, one dose was at Rwf100,000 for patients without health insurance – they required three doses a year. It has since reduced to Rwf 30,000 but still many people would not afford it. Now, we expect the price to reduce up to Rwf5,000 thanks to this partnership”.